cardene in 0.86% sodium chloride in plastic container Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cardene In 0.86% Sodium Chloride In Plastic Container, and when can generic versions of Cardene In 0.86% Sodium Chloride In Plastic Container launch?
Cardene In 0.86% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. There are six patents protecting this drug.
This drug has twenty-one patent family members in ten countries.
The generic ingredient in CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardene In 0.86% Sodium Chloride In Plastic Container
A generic version of cardene in 0.86% sodium chloride in plastic container was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for cardene in 0.86% sodium chloride in plastic container?
- What are the global sales for cardene in 0.86% sodium chloride in plastic container?
- What is Average Wholesale Price for cardene in 0.86% sodium chloride in plastic container?
Summary for cardene in 0.86% sodium chloride in plastic container
International Patents: | 21 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 9 |
Formulation / Manufacturing: | see details |
DailyMed Link: | cardene in 0.86% sodium chloride in plastic container at DailyMed |
Recent Clinical Trials for cardene in 0.86% sodium chloride in plastic container
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
Vanderbilt University Medical Center | Phase 2 |
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
See all cardene in 0.86% sodium chloride in plastic container clinical trials
Pharmacology for cardene in 0.86% sodium chloride in plastic container
US Patents and Regulatory Information for cardene in 0.86% sodium chloride in plastic container
cardene in 0.86% sodium chloride in plastic container is protected by six US patents.
Patents protecting cardene in 0.86% sodium chloride in plastic container
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Methods of treatment with pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: METHOD FOR TREATING ACUTE ELEVATIONS OF BLOOD PRESSURE IN HUMAN SUBJECT IN NEED THEREOF
Pre-mixed, ready-to-use pharmaceutical compositions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
International Patents for cardene in 0.86% sodium chloride in plastic container
See the table below for patents covering cardene in 0.86% sodium chloride in plastic container around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2018152 | COMPOSITIONS PHARMACEUTIQUES PRÉMÉLANGÉES PRÊTES À L'EMPLOI (PRE-MIXED, READY-TO-USE PHARMACEUTICAL COMPOSITIONS) | ⤷ Sign Up |
Spain | 423445 | ⤷ Sign Up | |
Japan | S504082 | ⤷ Sign Up | |
Finland | 58772 | ⤷ Sign Up | |
Canada | 1029022 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |